How much they sold
About 113.7m
Operating income / revenue in 2025.
Simple version
Explain it like I’m ten
Numbers from the 2025 accounts. [R2025]
Did they make money?
8.5m
Net result for 2025.
What’s left in the company
Equity 56.6m
Book equity at year-end.
Cash
180.5k
Bank deposits and cash (when disclosed).
At a glance · 2025
Key figures
Revenue / sales
113 724 064
NOK · [R2025]
Net result
8 520 812
NOK · [R2025]
Equity
56 624 853
NOK · [R2025]
Cash
180 485
NOK · [R2025]
Total assets
148 529 993
NOK · [R2025]
Paid-in equity
83 303 819
NOK · [R2025]
Trends
4-year arc
Charts use figures extracted from published annual reports.
Sales / revenue
Equity & cash
Cost / investment lines
Salary costs (lønnskostnader)
FTEs (årsverk)
From notes when disclosed; blank years mean not found in OCR.
Analyst briefing
Company read — signals, board & numbers
Auto-written from filings, Brreg kunngjøringer, board timeline, address history, and the signal board. Interpretive — not investment advice.
Year by year
Comparing consecutive annual reports
Each filing pair has a dedicated, crawlable article page. Below is a preview of the latest comparison.
Executive summary
Auto-generated from filings
AKER BIOMARINE HUMAN INGREDIENTS AS · 4 published annual accounts (2022–2025). Latest year revenue 113.7m NOK, net result 8.5m NOK, equity 56.6m NOK, cash 180.5k NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall. Interpretation
What improved
Vs prior year
What deteriorated
Vs prior year
No clear deteriorations vs prior year on the core lines.
Buyer profile
What they may buy next
Sales-oriented read of industry, stage, filings, and registry signals — what this company is likely to purchase or hire over the next year. Interpretive, not a stated budget.
Health metrics
Ratios from the accounts
Source citations
Every material claim traces here
- [R2022] Årsregnskap 2022 · journal — · approved — · registry —
- [R2023] Årsregnskap 2023 · journal 2024 738360 · approved 20.08.2024 · registry 02.09.2024
- [R2024] Årsregnskap 2024 · journal 2025 673050 · approved 20.06.2025 · registry 17.07.2025
- [R2025] Årsregnskap 2025 · journal 2026 534187 · approved 28.05.2026 · registry 04.07.2026
Original annual reports
Source documents
Signals
Hard · medium · soft
Derived from published accounts, Brreg roles, and kunngjøringer. Soft signals are interpretive — not facts or buying proof.
Registered address
Where the company sat over time
From Brreg «Endring av forretningsadresse» filings. Hubs and c/o addresses are tagged so you can see the path from incubator to own office.
Board & management
Who joined and left
Diffed from Styre / Daglig leder kunngjøringer (full public history).
Løsøreregisteret
Heftelser & rettsstiftelser
Active pant / utlegg and other registrations from Brreg’s public rettsstiftelser oppslag (not a full credit report).
Kunngjøringer
Full registry history
Ownership
Owners, officers & filing notes
Prefer Skatteetaten’s Aksjonærregisteret when available. Otherwise FirmaIQ shows Brreg officers (name + birth date) and any shareholder names disclosed in the annual-report «Aksjeeiere» note.